These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 4733838)

  • 1. Cyclic peptides. VI. Europium-assisted nuclear magnetic resonance study of the solution conformations of cyclo(L-Pro-L-Pro) and cyclo(L-Pro-D-Pro).
    Young PE; Madison V; Blout ER
    J Am Chem Soc; 1973 Sep; 95(18):6142-4. PubMed ID: 4733838
    [No Abstract]   [Full Text] [Related]  

  • 2. Cyclic peptides. 3. Solution conformations of cyclo(serylprolylglycylserylprolylglycyl) from nuclear magnetic resonance.
    Torchia DA; Wong SC; Deber CM; Blout ER
    J Am Chem Soc; 1972 Jan; 94(2):616-20. PubMed ID: 5060992
    [No Abstract]   [Full Text] [Related]  

  • 3. Cyclic peptides. II. Solution conformations of cyclo(ProlyLserylglycylprolylserylglycyl) from nuclear magnetic resonance.
    Torchia DA; Di Corato A; Wong SC; Deber CM; Blout ER
    J Am Chem Soc; 1972 Jan; 94(2):609-15. PubMed ID: 5060991
    [No Abstract]   [Full Text] [Related]  

  • 4. Influence of D and L amino-acid residues on the conformation of peptides in solution: A carbon-13 nuclear magnetic resonance study of cyclo(prolyl-leucyl).
    Deslauriers R; Grzonka Z; Walter R
    Biopolymers; 1976 Sep; 15(9):1677-83. PubMed ID: 963256
    [No Abstract]   [Full Text] [Related]  

  • 5. Conformations of psi [CH2NH] pseudopeptides. Cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro]-TFA and cyclo[Gly-Pro psi [CH2NH]Gly-D-Phe-Pro].
    Ma S; Spatola AF
    Int J Pept Protein Res; 1993 Feb; 41(2):204-6. PubMed ID: 8458694
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic hexapeptides bearing carboxyl groups. Interaction with metal ions and lipid membrane.
    Ozeki E; Miyazu T; Kimura S; Imanishi Y
    Int J Pept Protein Res; 1989 Aug; 34(2):97-103. PubMed ID: 2807735
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Solution conformations of two flexible cyclic pentapeptides: cyclo(Gly-Pro-D-Phe-Gly-Ala) and cyclo(Gly-Pro-D-Phe-Gly-Val).
    Stroup AN; Rockwell AL; Gierasch LM
    Biopolymers; 1992 Dec; 32(12):1713-25. PubMed ID: 1472654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 1H- and 13C-nuclear magnetic resonance spectroscopy, and its enantioface-differentiating ability.
    Ishizu T; Fujii A; Noguchi S
    Chem Pharm Bull (Tokyo); 1993 Feb; 41(2):235-8. PubMed ID: 8500196
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The conformation of cyclo(-D-Pro-Ala4-) as a model for cyclic pentapeptides of the DL4 type.
    Heller M; Sukopp M; Tsomaia N; John M; Mierke DF; Reif B; Kessler H
    J Am Chem Soc; 2006 Oct; 128(42):13806-14. PubMed ID: 17044709
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conformational studies of cyclo(L-Phe-L-Pro-Gly-L-Pro)2 by 13C nuclear magnetic resonance.
    Ishizu T; Fujii A; Noguchi S
    Chem Pharm Bull (Tokyo); 1991 Jun; 39(6):1617-9. PubMed ID: 1934186
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Conformations of an ion-binding cyclic peptide analogue of valinomycin, cyclo(L-Val-Gly-Gly-L-Pro)3.
    Easwaran KR; Pease LG; Blout ER
    Biochemistry; 1979 Jan; 18(1):61-7. PubMed ID: 420778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A 1H-NMR study of the solution conformation of cyclo(GRGDSPA): conformational effects on the physiological activity.
    Mizutani R; Shimada I; Ueno Y; Yoda M; Kumagai H; Arata Y
    Biochem Biophys Res Commun; 1992 Jan; 182(2):966-73. PubMed ID: 1734894
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclic peptides. IX. Conformations of a synthetic ion-binding cyclic peptide, cyclo-(pro-gly)3, from circular dichroism and 1H and 13C nuclear magnetic resonance.
    Madison V; Atreyi M; Deber CM; Blout ER
    J Am Chem Soc; 1974 Oct; 96(21):6725-34. PubMed ID: 4412689
    [No Abstract]   [Full Text] [Related]  

  • 14. Conformations of cyclic octapeptides. 4. Diastereomers of cyclo(Gly-Pro-Phe-Ala-Asn-Ala-Val-Ser).
    Vishwanath CK; Go A; Parameswaran KN; Wang YS; Kopple KD
    Int J Pept Protein Res; 1986 Oct; 28(4):428-36. PubMed ID: 3793373
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multiple solution conformations of the integrin-binding cyclic pentapeptide cyclo(-Ser-D-Leu-Asp-Val-Pro-). Analysis of the (phi, psi) space available to cyclic pentapeptides.
    Viles JH; Mitchell JB; Gough SL; Doyle PM; Harris CJ; Sadler PJ; Thornton JM
    Eur J Biochem; 1996 Dec; 242(2):352-62. PubMed ID: 8973654
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Conformations of cyclic peptides. V. A proton magnetic resonance study of evolidine, cyclo-ser-phe-leu-pro-val-asn-leu.
    Kopple KD
    Biopolymers; 1971; 10(7):1139-52. PubMed ID: 5095088
    [No Abstract]   [Full Text] [Related]  

  • 17. Conformational and ion binding properties of a cyclic octapeptide, cyclo (Ala-Leu-Pro-Gly)2.
    Jois DS; Easwaran KR; Bednarek M; Blout ER
    Biopolymers; 1992 Aug; 32(8):993-1001. PubMed ID: 1420982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conformational analysis of two cyclic analogs of angiotensin: implications for the biologically active conformation.
    Nikiforovich GV; Kao JL; Plucinska K; Zhang WJ; Marshall GR
    Biochemistry; 1994 Mar; 33(12):3591-8. PubMed ID: 8142357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cyclic peptides. XIX. Synthesis, conformation, and biological activity of cyclo(-Pro-Val-Pro-Val-) with L-L-L-L and L-D-L-D sequences.
    Ueda T; Sada I; Kato T; Izumiya N
    Int J Pept Protein Res; 1985 May; 25(5):475-80. PubMed ID: 4019028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cyclic peptides. XIV. Syntheses of [4-l-leucine]-, [4-D-leucine]-, and [3-L-proline, 4-D-leucine]-Cyl-2.
    Yasutake A; Aoyagi H; Sada I; Kato T; Izumiya N
    Int J Pept Protein Res; 1982 Sep; 20(3):246-53. PubMed ID: 7129757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.